Synopsis of recent research by authors named "Daniel Kurnik"
Daniel Kurnik's recent research focuses on clinical pharmacy interventions and the effects of drug interactions and exposures within specific patient populations, particularly in oncology and critical care settings.
His studies highlight critical issues such as the need for deprescribing strategies in hospitalized cancer patients and the implications of drug adulteration in substance use, emphasizing severe coagulopathy cases linked to synthetic cannabinoids.
Kurnik's work also delves into pharmacokinetics of antibiotics in critically ill patients and the medication burden faced by pediatric cancer patients, contributing valuable insights to optimize treatment outcomes and safety.
